Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immucell Cp (ICCC)

Immucell Cp (ICCC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
Global animal vaccine market is forecast to grow from an estimated $ 6.3 billion in 2019 to $ 8.1 billion by 2025

, /PRNewswire/ --  Read the full report: Global animal vaccine market is forecast to grow from an estimated in 2019 to by 2025. Rising meat consumption is a major factor driving the market. Another...

ICCC : 6.10 (+2.35%)
MRK : 81.90 (+0.43%)
NEOG : 74.20 (-0.72%)
VRBCF : 247.0000 (+1.23%)
ZTS : 160.72 (-0.40%)
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
Timing the Market, Is it Possible? - August 07, 2020

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

CLBS : 1.5300 (+2.00%)
ICCC : 6.10 (+2.35%)
HNGR : 23.02 (-0.30%)
VBIV : 3.13 (-1.26%)
KRMD : 5.08 (+3.67%)
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Receives $500,000 Loan from the Maine Technology

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
Animal Vaccines Market to Exhibit 6.4% CAGR by 2027; Government-imposed Regulations on Timely Animal Vaccination to Aid in Expansion of Market says Fortune Business Insights(TM)

The global Animal Vaccines Market size is projected to hit USD 16.01 billion by the end of 2026 attributed to the increasing awareness about animal diseases and the increasing importance of animal health...

LLY : 146.30 (+0.51%)
ICCC : 6.10 (+2.35%)
MRK : 81.90 (+0.43%)
NEOG : 74.20 (-0.72%)
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference

, /PRNewswire/ --  (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

ICCC : 6.10 (+2.35%)
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

ImmuCell Corporation (Nasdaq: ICCC) (the "Company" or "ImmuCell"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Receives $938,000 in Support under the Paycheck Protection Program

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Refinancing of its Bank Debt

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 6.10 (+2.35%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar